{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChange": -0.13999939, "regularMarketTime": 1683875702, "regularMarketDayHigh": 10.76, "regularMarketDayRange": "10.76 - 10.76", "regularMarketDayLow": 10.76, "regularMarketVolume": 87, "regularMarketPreviousClose": 10.9, "bid": 10.82, "ask": 11.22, "fullExchangeName": "Frankfurt", "financialCurrency": "NOK", "regularMarketOpen": 10.76, "averageDailyVolume3Month": 1, "averageDailyVolume10Day": 8, "fiftyTwoWeekLowChange": 5.2400002, "fiftyTwoWeekLowChangePercent": 0.94927543, "fiftyTwoWeekRange": "5.52 - 12.16", "fiftyTwoWeekHighChange": -1.3999996, "fiftyTwoWeekHighChangePercent": -0.11513155, "fiftyTwoWeekLow": 5.52, "fiftyTwoWeekHigh": 12.16, "exchange": "FRA", "shortName": "ULTIMOVACS ASA  NK0,1", "longName": "Ultimovacs ASA", "messageBoardId": "finmb_241624822", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -1.2843981, "regularMarketPrice": 10.76, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.41, "sharesOutstanding": 34396500, "bookValue": 13.064, "fiftyDayAverage": 10.1584, "fiftyDayAverageChange": 0.60160065, "fiftyDayAverageChangePercent": 0.05922199, "twoHundredDayAverage": 8.9549, "twoHundredDayAverageChange": 1.8051004, "twoHundredDayAverageChangePercent": 0.20157684, "marketCap": 370106336, "priceToBook": 0.8236375, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1559714400000, "priceHint": 2, "symbol": "7UM.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Ullernchauss\u00e9en 64", "city": "Oslo", "zip": "0379", "country": "Norway", "phone": "47 41 38 00 80", "website": "https://ultimovacs.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.", "fullTimeEmployees": 22, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carlos  de Sousa", "age": 64, "title": "Chief Exec. Officer", "yearBorn": 1958, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Hans Vassg\u00e5rd Eid", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Ingunn Hagen Westgaard Ph.D.", "title": "Head of Research", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Audun  Tornes", "title": "Chief Technology Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anne H. Worsoe", "title": "Head of Investor Relations & ESG", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jens Egil Torbjorn Bjorheim M.D., Ph.D.", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Oivind  Foss Ph.D.", "title": "Head of Clinical Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Gudrun  Troite Ph.D.", "title": "Head of Project Coordination", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Antonius  Berkien", "age": 54, "title": "Chief Bus. Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Orla  Mc Callion", "title": "Head of Regulatory Affairs & QA", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}